NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008
| NCT ID | NCT03275311 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNICANCER |
| Condition | Metastatic Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 42,000 participants |
| Start Date | 2014-07 |
| Primary Completion | 2027-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 42,000 participants in total. It began in 2014-07 with a primary completion date of 2027-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Epidemiological Strategy and Medical Economic (ESME) Breast cancer Database is a multicenter real life database using a retrospective data collection process across 18 French comprehensive cancer centers (FCCC) spread over 20 sites. This database compiles data from patient's electronic medical records (EMR).
Eligibility Criteria
Inclusion criteria : * 18 years old patient * Patient receiving chemotherapy, targeted therapy, immunotherapy, radiation therapy and hormonotherapy in a French Comprehensive Cancer Center. Exclusion criteria : None
Contact & Investigator
Lise Bosquet, MsC
✉ l-bosquet@unicancer.frLise Bosquet, MsC
STUDY DIRECTOR
UNICANCER
Frequently Asked Questions
Who can join the NCT03275311 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Metastatic Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03275311 currently recruiting?
Yes, NCT03275311 is actively recruiting participants. Contact the research team at l-bosquet@unicancer.fr for enrollment information.
Where is the NCT03275311 trial being conducted?
This trial is being conducted at Angers, France, Bordeaux, France, Caen, France, Clermont-Ferrand, France and 11 additional locations.
Who is sponsoring the NCT03275311 clinical trial?
NCT03275311 is sponsored by UNICANCER. The principal investigator is Lise Bosquet, MsC at UNICANCER. The trial plans to enroll 42,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.